Pesquisas alternativas:
disease developing » disease development (Expandir a Pesquisa), diseases development (Expandir a Pesquisa), disease depending (Expandir a Pesquisa)
developing type » developing novel (Expandir a Pesquisa)
de developing » late developing (Expandir a Pesquisa), care developing (Expandir a Pesquisa), de development (Expandir a Pesquisa)
drug disease » drug release (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
disease developing » disease development (Expandir a Pesquisa), diseases development (Expandir a Pesquisa), disease depending (Expandir a Pesquisa)
developing type » developing novel (Expandir a Pesquisa)
de developing » late developing (Expandir a Pesquisa), care developing (Expandir a Pesquisa), de development (Expandir a Pesquisa)
drug disease » drug release (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
1
Por Kitamoto, Tetsuyuki., International Symposium of Prion Diseases for Food and Drug Safety
Publicado em 2005
“... (vCJD) in the United Kingdom. In 2004, the International symposium of prion diseases for food and drug...”Publicado em 2005
Obter o texto integral
Livro
2
Por Mittermayer, Friedrich, Caveney, Erica, Oliveira, Claudia De, Gourgiotis, Loukas, Puri, Mala, Tai, Li-Jung, J, Rick Turner
Publicado no Curr Diabetes Rev (2015)
“... of this disease needs constant provision of new drugs. Twelve classes of antidiabetic drugs are currently...”Publicado no Curr Diabetes Rev (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“... termination of drug development or withdrawal of drugs from the market. Management of such interactions...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Gorter, Kees J, van de Laar, Floris Alexander, Janssen, Paul G H, Houweling, Sebastian T, Rutten, Guy E H M
Publicado em 2012
“...% of the adult population. Type 2 diabetes may occur with obesity, hypertension, and dyslipidaemia (the metabolic...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Artigo
5
Por Zhang, Jian-Xin, Wang, Kun, Mao, Zheng-Fa, Fan, Xin, Jiang, De-Li, Chen, Min, Cui, Lei, Sun, Kang, Dang, Sheng-Chun
Publicado em 2013
“... different types and uses of liposomes in the development of therapeutics for gastrointestinal diseases...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
7
Por Paola eImbrici, Antonella eLiantonio, Giulia Maria eCamerino, Michela eDe Bellis, Claudia eCamerino, Antonietta eMele, Arcangela eGiustino, Sabata ePierno, Annamaria eDe Luca, Domenico eTricarico, Jean-Francois eDesaphy, Diana eConte
Publicado em 2016-05-01
Assuntos:
“...Drug discovery and development...”Publicado em 2016-05-01
Obter o texto integral
Artigo
8
“...Renal and cardiovascular complications make type 2 diabetes one of the most morbid conditions...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Federico, Alessandro, Zulli, Claudio, de Sio, Ilario, Del Prete, Anna, Dallio, Marcello, Masarone, Mario, Loguercio, Carmela
Publicado no World J Gastroenterol (2014)
“... countries and is increasingly being recognized in developing nations. Fatty liver disease encompasses a...”Publicado no World J Gastroenterol (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Natália Prudente de Mello, Ana Maria Orellana, Caio Henrique Mazucanti, Geovanni de Morais Lima, Cristoforo Scavone, Elisa Mitiko Kawamoto
Publicado em 2019-05-01
Assuntos:
“...type 2 diabetes...”Publicado em 2019-05-01
Obter o texto integral
Artigo
11
Por Fernandez-Cruz, E, Fernandez, A M, Gutierrez, C, Garcia-Montes, M, de la Morena, M T, Rodriguez-Villanueva, J, Longo, N, Zabay, J M
Publicado em 1988
“...-negative drug abusers. Ninety percent of the 264 drug addicts (mean age 26 +/- 0.8 years) were found...”Publicado em 1988
Obter o texto integral
Obter o texto integral
Artigo
12
Por Green, Ezekiel, Obi, Lawrence C., Okoh, Anthony I., Nchabeleng, Maphoshane, Villiers, Babsie E. De, Letsoalo, Tomas, Hoosen, Anwar A., Bessong, Pascal O., Ndip, Roland N.
Publicado em 2013
“...Tuberculosis (TB) remains a deadly infectious disease affecting millions of people worldwide; 95...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Artigo
13
Por Bacci, Marcelo Rodrigues, Cavallari, Marina Romera, de Rozier-Alves, Ross Martin, Alves, Beatriz da Costa Aguiar, Fonseca, Fernando Luiz Affonso
Publicado no Drug Des Devel Ther (2015)
“... kidney disease as well as risk factors for cardiovascular events. In recent years, lipocalin-type...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por de Boer, Richard, Smith, Ruben L., De Vos, Winnok H., Manders, Erik M. M., Brul, Stanley, van der Spek, Hans
Publicado no PLoS One (2015)
“... is crucial. We therefore set out to develop the use of Caenorhabditis elegans to study drug induced...”Publicado no PLoS One (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Sablón-Carrazana, Marquiza, Fernández, Isaac, Bencomo, Alberto, Lara-Martínez, Reyna, Rivera-Marrero, Suchitil, Domínguez, Guadalupe, Pérez-Perera, Rafaela, Jiménez-García, Luis Felipe, Altamirano-Bustamante, Nelly F., Diaz-Delgado, Massiel, Vedrenne, Fernand, Rivillas-Acevedo, Lina, Pasten-Hidalgo, Karina, Segura-Valdez, María de Lourdes, Islas-Andrade, Sergio, Garrido-Magaña, Eulalia, Perera-Pintado, Alejandro, Prats-Capote, Anaís, Rodríguez-Tanty, Chryslaine, Altamirano-Bustamante, Myriam M.
Publicado no PLoS One (2015)
“...The increasing prevalence of conformational diseases, including Alzheimer's disease, type 2...”Publicado no PLoS One (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por de Valk, Harold W.
Publicado em 2008
“... developed drugs. The new insights from the trials presented on the EASD meeting 2008 and the emerging...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
A human liver microphysiology platform for investigating physiology, drug safety, and disease models
Por Vernetti, Lawrence A, Senutovitch, Nina, Boltz, Robert, DeBiasio, Richard, Ying Shun, Tong, Gough, Albert, Taylor, D Lansing
Publicado no Exp Biol Med (Maywood) (2015)
“...This paper describes the development and characterization of a microphysiology platform for drug...”Publicado no Exp Biol Med (Maywood) (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
“... of these patients at 5-years survival is very low. Because of these poor statistics, the development of new drugs...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
20
Por Imbrici, Paola, Liantonio, Antonella, Camerino, Giulia M., De Bellis, Michela, Camerino, Claudia, Mele, Antonietta, Giustino, Arcangela, Pierno, Sabata, De Luca, Annamaria, Tricarico, Domenico, Desaphy, Jean-Francois, Conte, Diana
Publicado no Front Pharmacol (2016)
“... to drugs: this opens the way to a pharmacogenetics strategy, allowing the development of a personalized...”Publicado no Front Pharmacol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo